Avidity Stock Soars on Collaboration Deal With Bristol Myers
Bristol Myers agrees to pay Avidity $60 million in cash and also will purchase about $40 million of Avidity common stock at $7.88 a share.
Source: marketwatch.com
Page 31 - Rna News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Rna. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Rna Today - Breaking & Trending Today
New RNA-based Therapy Combats Melanoma in Mouse Models
Investigators at the Icahn School of Medicine at Mount Sinai have designed an innovative RNA-based strategy to activate dendritic cells—which play a key role in immune response—that eradicated tumors and prevented their recurrence in mouse models of melanoma.
Source: onclive.com
BioEcho introduces EchoLUTION™ FFPE RNA Kit for superior RNA extraction from FFPE tissues
A leading provider of innovative molecular biology solutions, announces the launch of its EchoLUTION FFPE RNA Kit.
Source: news-medical.net
How Viome Uses AI In Making 'Precision Nutrition' And Wellness Accessible To All
Viome builds at-home tests, shipping direct to its customers, which are designed to help people formulate a better understanding of their health.
Source: forbes.com
Avidity Biosciences (RNA) Scheduled to Post Earnings on Monday
Avidity Biosciences (NASDAQ:RNA – Get Free Report) will be posting its quarterly earnings results on Monday, November 6th. Avidity Biosciences (NASDAQ:RNA – Get Free Report) last released its quarterly earnings data on Tuesday, August 8th. The biotechnology company reported ($0.66) earnings per share for the quarter, beating the consensus estimate of ($0.84) by $0.18. The […]
Source: wkrb13.com